Oct 13, 2022
Great news from OpenSpecimen! We proudly announce that on 13th Sept 2022, the University Medical Center Utrecht (Netherlands) central biobank successfully migrated from its old BIMS to OpenSpecimen.
May 15, 2021
Current Adoption Status: 67 collection protocols / 40+ active usersPublished 67 peer-reviewed articlesSupported 20 grantsManages 400K specimens for 40K study participants100+K specimens sent to Precision Medicine platform *Reference: 2019 OpenSpecimen...
Apr 29, 2021
The Mouse Biology Program (MBP) of the University of California, Davis (UCD) is the largest academic program in the world. MBP is a member of the NIH-funded Mutant Mouse Resource and Research Centers (MMRRC).
Apr 05, 2021
Srikanth Adiga (CEO, OpenSpecimen) talks to Dave Mulvihill and Lee Myrick from Washington University's "OpenSpecimen Implementation Team" to understand their internal processes, training mechanisms, & best practices.
Mar 23, 2021
COVID-19 has infected more than 110 million individuals worldwide, with about 2.5 million deaths. It is very crucial to find an intervention that successfully prevents or mitigates morbidity and mortality.
Mar 20, 2021
Currently, biobanks at the University Hospital Basel (USB) are not centralized. Storage locations are distributed over organizational units, which partly are about to be centrally managed.
Mar 03, 2021
University of California (Davis) Pathology Biorepository has been using OpenSpecimen as their Biobanking LIMS since 2010. We interview Irmi Feldman (Biorepostiory Manager) to understand the work and life of a biobanker.
Feb 02, 2021
The University of Maryland School of Medicine established a biorepository intending to provide the resources and support for large-scale studies. Currently, the UMM Biorepository has data of 28000+ participants and 400000+ specimens.
Jan 18, 2021
"According to Darwin's Origin of Species, it is not the strongest of the species that survives, nor the most intellectual; but the one most adaptable to change." – Leon C.
Apr 09, 2019
As funding bodies push for translational research, more researchers need access to biospecimens and de-identified clinical data.